<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-�� inhibitors
doi: 10.34894/3jlg5c
Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-�� inhibitors
Objective: To investigate the influence of patient characteristics on the course of spinal radiographic progression in a large prospective longitudinal cohort study of ankylosing spondylitis (AS) patients treated long-term with TNF-�� inhibitors. Methods: Consecutive patients from the Groningen Leeuwarden AS (GLAS) cohort starting TNF-�� inhibitors with spinal radiographs at least available at baseline and 6 years of follow-up were included. Radiographs were scored using mSASSS by two independent readers. Generalized estimating equations (GEE) were used to explore the associations between baseline characteristics and spinal radiographic progression. The course of radiographic progression in patients with and without risk factors for poor radiographic outcome was investigated using different time models (linear and non-linear). Single linear imputation was used in case of missing radiographic data at the intermediate (2 or 4 years) follow-up visits. Results: 80 AS patients were included with mean baseline mSASSS 8.7��13.3. Baseline syndesmophytes, male gender, older age, longer symptom duration, smoking, and higher BMI were significantly associated with more radiographic damage over time. GEE analysis in patients with these risk factors revealed that radiographic progression followed a non-linear course with mean mSASSS progression rates reducing from max. 2.8 units over 0-2 years to min. 0.9 units over 4-6 years. The GEE model revealed a linear course with overall very low progression (���1 mSASSS units/2yrs) in patients without risk factors. Complete case analysis in 53 patients showed similar results. Conclusion: AS patients at risk of poor radiographic outcome showed the highest but diminishing spinal radiographic progression during long-term treatment with TNF-�� inhibitors.
- Leiden University Netherlands
- Dutch Research Council Netherlands
- Maastricht University, University Library Netherlands
- The Dataverse Project United States
- Utrecht University Netherlands
Health and Life Sciences, tumor necrosis factor-alpha blocking therapy, Rheumatology, Medicine, Health and Life Sciences, radiographic progression, ankylosing spondylitis, tumor necrosis factor alpha blocking therapy, Medicine, Life Sciences, risk factors, bone formation
Health and Life Sciences, tumor necrosis factor-alpha blocking therapy, Rheumatology, Medicine, Health and Life Sciences, radiographic progression, ankylosing spondylitis, tumor necrosis factor alpha blocking therapy, Medicine, Life Sciences, risk factors, bone formation
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average